Hugo, Janice P.
HRN: 22-05-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2022
CEFTRIAXONE 1G (VIAL)
10/03/2022
10/09/2022
IV
2g
OD
T/C Leptospirosis, T/C Typhoid Fever
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes